Mycophenolate mofetil hydrochloride

This classification denotes an inosine monophosphate dehydrogenase inhibitor and immunosuppressant with the molecular formula C23H31NO7.ClH, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier UXH81S8ZVB, chemically known as 4-hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, hydrochloride, (e)- but more generally known as mycophenolate mofetil hydrochloride, which bears US NIH Compound Identifier 6441022. European Medicines Agency schedules Mycophenolate mofetil hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32913. Mycophenolate mofetil hydrochloride bears US NLM identifiers UMLS ID C0772450 and NCI Concept Code C61852. Most nations, for tariff and trade purposes, schedule mycophenolate mofetil hydrochloride under 29419000 and SITC 54139. SMILES: CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)OCCN3CCOCC3)OC.Cl.